Work

Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma

Year: 2010

Type: article

Study design: Clinical Trial

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2009.12.052

Authors: Youn H. Kim, Michael Girardi, Madeleine Duvic, Timothy Kuzel, Brian K. Link, Lauren Pinter-Brown, Alain H. Rook

Institutions: Stanford Medicine, Stanford Cancer Institute, Stanford University, Yale University, The University of Texas MD Anderson Cancer Center, Northwestern University, University of Iowa, University of California, Los Angeles, University of Pennsylvania

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2128852153

FWCI: 10.06

Cites: 31

Cited by: 115

Related to: 10